(VIANEWS) - SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF (DAC), JD.com (JD), One Stop Systems (OSS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF (DAC)
49.4% sales growth and 56.75% return on equity
Danaos Corporation, together with its subsidiaries, owns and operates containerships in Australia, Asia, Europe, and the United States.
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's sales growth this year is expected to be 34.1% and 25.4% for next year.
Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 517.13M for the twelve trailing months.
Volume
Today's last reported volume for SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF is 449012 which is 29.29% above its average volume of 347285.
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's sales growth is a negative 0% for the ongoing quarter and 49.4% for the next. The company's growth estimates for the present quarter and the next is 100% and 77.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 56.75%.
Volatility
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's last day, last week, and last month's current volatility was 2.54%, 3.17%, and 2.77%, respectively.
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.40% (day), 5.33% (last week), and 4.82% (last month), respectively.
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's Stock Yearly Top and Bottom Value
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's stock is valued at $72.64 at 05:22 EST, way under its 52-week high of $89.41 and way above its 52-week low of $10.50.
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's Moving Average
SPDR (R) Ser Tr-SPDR Wells Fargo Preferred Stock ETF's value is under its 50-day moving average of $75.27 and above its 200-day moving average of $71.63.2. JD.com (JD)
25.8% sales growth and 31.53% return on equity
JD.com, Inc., through its subsidiaries, operates as an e-commerce company and retail infrastructure service provider in the People's Republic of China.
JD.com's sales growth this year is expected to be 28.1% and 22.7% for next year.
Year-on-year quarterly revenue growth grew by 39%, now sitting on 802.77B for the twelve trailing months.
Volume
Today's last reported volume for JD.com is 4289760 which is 54.65% below its average volume of 9460140.
JD.com's sales growth for the next quarter is 25.8%. The company's growth estimates for the present quarter and the next is a negative 39.6% and negative -39.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.53%.
Volatility
JD.com's last day, last week, and last month's current volatility was 0.13%, 1.60%, and 1.69%, respectively.
JD.com's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.97% (day), 2.77% (last week), and 2.90% (last month), respectively.
JD.com's Stock Yearly Top and Bottom Value
JD.com's stock is valued at $77.19 at 05:22 EST, way below its 52-week high of $108.29 and way above its 52-week low of $61.65.
JD.com's Moving Average
JD.com's value is under its 50-day moving average of $78.12 and higher than its 200-day moving average of $74.93.Previous days news about JD.com(JD)
- According to Bloomberg Quint on Tuesday, 9 November, "The PBOC has partnered with tech giants including Ant Group and JD.com Inc to promote the digital currency, and users in pilot zones can access their e-CNY wallet through Ant's Alipay app or top up funds."
- According to Bloomberg Quint on Monday, 8 November, "Domestic rivals have also rolled out promotions to cash in; JD.com Inc. started pre-sales on Oct. 31 and said it sold 190 million products within the first four hours, from mobile phones to vacuum cleaners. "
3. One Stop Systems (OSS)
18.5% sales growth and 8.29% return on equity
One Stop Systems, Inc. designs, manufactures, and markets high-performance computing modules and systems for edge deployments in the United States and internationally.
One Stop Systems's sales growth this year is anticipated to be 16.8% and 10.9% for next year.
Year-on-year quarterly revenue growth grew by 28.2%, now sitting on 55.13M for the twelve trailing months.
Volume
Today's last reported volume for One Stop Systems is 32184 which is 66.65% below its average volume of 96521.
One Stop Systems's sales growth for the next quarter is 18.5%. The company's growth estimates for the current quarter and the next is a negative 0% and 500%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.29%.
Volatility
One Stop Systems's last day, last week, and last month's current volatility was 0.56%, 2.28%, and 1.94%, respectively.
One Stop Systems's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.54% (day), 4.60% (last week), and 3.77% (last month), respectively.
One Stop Systems's Stock Yearly Top and Bottom Value
One Stop Systems's stock is valued at $5.40 at 05:22 EST, way under its 52-week high of $9.50 and way higher than its 52-week low of $2.20.
One Stop Systems's Moving Average
One Stop Systems's worth is higher than its 50-day moving average of $5.11 and under its 200-day moving average of $5.49.4. Belden (BDC)
18% sales growth and 14.88% return on equity
Belden Inc. operates as a signal transmission solutions company in the United States and internationally.
Belden's sales growth this year is anticipated to be 28.6% and 3.5% for next year.
Year-on-year quarterly revenue growth grew by 32.6%, now sitting on 2.27B for the twelve trailing months.
Volume
Today's last reported volume for Belden is 237222 which is 3.21% above its average volume of 229839.
Belden's sales growth for the next quarter is 18%. The company's growth estimates for the current quarter and the next is 41.1% and 20.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.88%.
Volatility
Belden's last day, last week, and last month's current volatility was 0.82%, 2.32%, and 1.50%, respectively.
Belden's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.89% (day), 4.36% (last week), and 2.66% (last month), respectively.
Belden's Stock Yearly Top and Bottom Value
Belden's stock is valued at $65.56 at 05:22 EST, under its 52-week high of $67.20 and way higher than its 52-week low of $33.12.
Belden's Moving Average
Belden's worth is higher than its 50-day moving average of $60.16 and way higher than its 200-day moving average of $53.82.5. AbbVie (ABBV)
8.8% sales growth and 48.86% return on equity
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.
AbbVie's sales growth this year is anticipated to be 23% and 6% for next year.
Year-on-year quarterly revenue growth grew by 33.9%, now sitting on 53.73B for the twelve trailing months.
Volume
Today's last reported volume for AbbVie is 2477830 which is 66.27% below its average volume of 7347880.
AbbVie's sales growth for the next quarter is 8.8%. The company's growth estimates for the current quarter and the next is 14.5% and 13.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.86%.
Volatility
AbbVie's last day, last week, and last month's current volatility was 0.97%, 0.78%, and 0.89%, respectively.
AbbVie's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.44% (day), 1.52% (last week), and 1.47% (last month), respectively.
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $115.61 at 05:22 EST, below its 52-week high of $121.53 and way above its 52-week low of $95.63.
AbbVie's Moving Average
AbbVie's value is above its 50-day moving average of $110.05 and above its 200-day moving average of $113.59.Previous days news about AbbVie(ABBV)
- AbbVie presents integrated efficacy and safety data from two phase 3 trials on risankizumab (skyrizi®) in psoriatic arthritis at ACR convergence 2021. According to Business Insider on Friday, 5 November, "Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.", "About AbbVie in RheumatologyFor more than 20 years, AbbVie has been dedicated to improving care for people living with rheumatic diseases. "
- According to Business Insider on Saturday, 6 November, "In Lawrence C. Strauss's "Meet the 6 Big Stocks Powering 2021's Top Dividend Mutual Funds," discover why AbbVie Inc (NYSE:ABBV), Bank of America Corp (NYSE:BAC), Cisco Systems Inc (NASDAQ:CSCO) and others are the leaders of the pack here. "
- According to Bloomberg Quint on Tuesday, 9 November, "In an example of how such a split can create value for stockholders, Abbott Laboratories spun off its pharmaceutical unit in 2013 as AbbVie Inc. while retaining its medical devices and diagnostics divisions. "
6. Globus Medical (GMED)
6.9% sales growth and 11.93% return on equity
Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders.
Globus Medical's sales growth this year is anticipated to be 20.5% and 9.2% for next year.
Year-on-year quarterly revenue growth grew by 6.3%, now sitting on 941.53M for the twelve trailing months.
Volume
Today's last reported volume for Globus Medical is 300626 which is 27.58% below its average volume of 415120.
Globus Medical's sales growth for the next quarter is 6.9%. The company's growth estimates for the ongoing quarter and the next is a negative 15.5% and 4.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.93%.
Volatility
Globus Medical's last day, last week, and last month's current volatility was 1.14%, 0.79%, and 0.96%, respectively.
Globus Medical's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.09% (day), 2.57% (last week), and 2.03% (last month), respectively.
Globus Medical's Stock Yearly Top and Bottom Value
Globus Medical's stock is valued at $77.53 at 05:22 EST, under its 52-week high of $84.23 and way higher than its 52-week low of $55.07.